Hepatocellular carcinoma (HCC) is the most frequent liver cancer with high lethality and low
five-year survival rates leading to a substantial worldwide burden for healthcare systems …

Hepatocellular carcinoma (HCC) is ranked as the 5 th common type of cancer worldwide
and is considered as the 3 rd common reason for cancer-related deaths. HCC often occurs …

Abstract This CIRSE Standards of Practice document is aimed at interventional radiologists
and provides best practices for performing transarterial chemoembolisation. It has been …

Abstract Transarterial chemoembolization with Lipiodol (Lipiodol TACE), also called
conventional TACE, was developed in the early 1980s and widely adopted worldwide after …

Background Chemoembolization (TACE) improves survival in cirrhotic patients with
hepatocellular carcinoma (HCC). The optimal schedule, or whether embolization (TAE) …

Background & Aims: To elucidate the survival of the patients with unresectable
hepatocellular carcinoma (HCC) who underwent transcatheter arterial lipiodol …

Percutaneous microwave coagulation therapy (PMCT) is a new therapeutic technique for the
treatment of solid neoplasms that uses an energy source different from those of other …

Since 1983, transcatheter oily chemoembolization (TOCE) with doxorubicin hydrochloride,
iodized oil, and gelatin sponge was used in 100 patients with hepatocellular carcinoma …

Hepatocellular carcinoma (HCC) remains a major public health problem. Transarterial
chemoembolization (TACE) is recognized as the standard of care for patients with …

PURPOSE: To elucidate major complications and their predisposing factors in transcatheter
oily chemoembolization (TOCE) for hepatic tumors. MATERIALS AND METHODS: In a …